These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7550788)

  • 1. Prevention and management of glucocorticoid-induced osteoporosis.
    Lane NE; Mroczkowski PJ; Hochberg MC
    Bull Rheum Dis; 1995 Aug; 44(5):1-4. PubMed ID: 7550788
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone treatment of men treated with glucocorticoids.
    Odell WD
    Arch Intern Med; 1996 Jun; 156(11):1133-4. PubMed ID: 8639006
    [No Abstract]   [Full Text] [Related]  

  • 4. Barriers in the management of glucocorticoid-induced osteoporosis.
    Guzman-Clark JR; Fang MA; Sehl ME; Traylor L; Hahn TJ
    Arthritis Rheum; 2007 Feb; 57(1):140-6. PubMed ID: 17266078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.
    Solomon DH; Katz JN; Cabral D; Patrick AR; Bukowski JF; Coblyn JS
    Arthritis Rheum; 2006 Dec; 55(6):873-7. PubMed ID: 17139663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etidronate and glucocorticoid induced osteoporosis.
    Ortego-Centeno N; Muñoz-Torres M; Callejas-Rubio JL; Riera-Montes M
    J Rheumatol; 2005 Jan; 32(1):199-200. PubMed ID: 15630758
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in prevention of glucocorticoid-induced osteoporosis.
    Saag KG; Gehlbach SH; Curtis JR; Youket TE; Worley K; Lange JL
    J Rheumatol; 2006 Aug; 33(8):1651-7. PubMed ID: 16845707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients.
    Tałałaj M; Gradowska L; Marcinowska-Suchowierska E; Durlik M; Gaciong Z; Lao M
    Transplant Proc; 1996 Dec; 28(6):3485-7. PubMed ID: 8962355
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on glucocorticoid-induced osteoporosis.
    Woolf AD
    Curr Opin Rheumatol; 2007 Jul; 19(4):370-5. PubMed ID: 17551369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Negative effects of steroids on bone mass. Guidelines for prevention of osteoporosis].
    Ljunghall S; Skoogh BE
    Lakartidningen; 1994 Nov; 91(47):4417-9. PubMed ID: 7808153
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of glucocorticoid-induced osteoporosis: why are we doing so poorly?
    Yood RA
    J Rheumatol; 2006 Aug; 33(8):1461-3. PubMed ID: 16881101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glucocorticoid-induced osteoporosis treatment algorithm].
    Payer J; Killinger Z; Brázdilová K
    Vnitr Lek; 2009 May; 55(5):506-11. PubMed ID: 19514617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucocorticoids on bone density.
    Rehman Q; Lane NE
    Med Pediatr Oncol; 2003 Sep; 41(3):212-6. PubMed ID: 12868121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced osteoporosis: considerations in ophthalmology.
    Cervantes RA; Kump LI; Neer RM; Foster CS
    Ophthalmology; 2004 Aug; 111(8):1437-8. PubMed ID: 15288968
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical features of fracture with glucocorticoid induced osteoporosis and rheumatoid arthritis].
    Nampei A; Hashimoto J
    Clin Calcium; 2006 Nov; 16(11):1866-70. PubMed ID: 17079854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).
    Nawata H; Soen S; Takayanagi R; Tanaka I; Takaoka K; Fukunaga M; Matsumoto T; Suzuki Y; Tanaka H; Fujiwara S; Miki T; Sagawa A; Nishizawa Y; Seino Y;
    J Bone Miner Metab; 2005; 23(2):105-9. PubMed ID: 15750687
    [No Abstract]   [Full Text] [Related]  

  • 19. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Rossi CM; Di Comite G
    N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of glucocorticoids on bone mineral density in patients with idiopathic thrombocytopenic purpura].
    Hasegawa M; Nisikawa M; Nomura S; Takubo T; Suehiro A; Saigo K; Hayashi K; Tamaki S; Mizutani M; Uemura Y; Kurata Y;
    Rinsho Ketsueki; 2005 Feb; 46(2):121-6. PubMed ID: 16447705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.